Literature DB >> 15114017

Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.

Mansun Law1, Geoffrey L Smith.   

Abstract

This chapter describes the methods for the study of binding and entry of the two different forms of vaccinia virus (VV)-the intracellular mature virus (IMV) and extracellular enveloped virus (EEV)-using immunofluorescent staining and confocal microscopy. After binding to or penetration of the cells, IMV, EEV, and virus cores are distinguished by different antibodies. Bound virus or penetrated cores are visualized and recorded by confocal microscopy and can be accurately counted. Although specific antibodies to IMV, EEV, and virus cores are required, this method is highly quantitative and also allows the recognition of virus aggregates, which would not be possible using other techniques, such as flow cytometry and radiolabeling of virus particles. Furthermore, this method bypasses the need for EEV purification that may damage the EEV membrane and release an IMV particle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114017     DOI: 10.1385/1-59259-789-0:187

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Authors:  Ramtin Rahbar; Thomas T Murooka; Anna A Hinek; Carole L Galligan; Antonella Sassano; Celeste Yu; Kishore Srivastava; Leonidas C Platanias; Eleanor N Fish
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts.

Authors:  Daniel Byrd; Tohti Amet; Ningjie Hu; Jie Lan; Sishun Hu; Qigui Yu
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

3.  Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors:  Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry.

Authors:  Kouki Morizono; Yiming Xie; Tove Olafsen; Benhur Lee; Asim Dasgupta; Anna M Wu; Irvin S Y Chen
Journal:  Cell Host Microbe       Date:  2011-04-21       Impact factor: 21.023

5.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

6.  Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide.

Authors:  S E Altmann; J C Jones; S Schultz-Cherry; C R Brandt
Journal:  Virology       Date:  2009-04-22       Impact factor: 3.616

7.  Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.

Authors:  Daniel Byrd; Nicole Shepherd; Jie Lan; Ningjie Hu; Tohti Amet; Kai Yang; Mona Desai; Qigui Yu
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

8.  Ligand-induced and nonfusogenic dissolution of a viral membrane.

Authors:  Mansun Law; Gemma C Carter; Kim L Roberts; Michael Hollinshead; Geoffrey L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Lipid membranes in poxvirus replication.

Authors:  Jason P Laliberte; Bernard Moss
Journal:  Viruses       Date:  2010-04-06       Impact factor: 5.818

10.  Antiviral activity of the EB peptide against zoonotic poxviruses.

Authors:  Sharon E Altmann; Curtis R Brandt; Peter B Jahrling; Joseph E Blaney
Journal:  Virol J       Date:  2012-01-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.